-
Mashup Score: 39
Nature – A comprehensive analysis of the cell-specific molecular regulatory mechanisms underlying post-traumatic stress disorder in the human prefrontal cortex.
Source: www.nature.comCategories: General Medicine NewsTweet
-
Mashup Score: 0
Emotionally intelligent AI can generate trust, motivate action, elevate the relationship between patients and their care teams, and drive meaningful change.
Source: www.statnews.comCategories: General Medicine NewsTweet-
AI-powered nudges for chronic disease care need emotional intelligence https://t.co/KHl8akufVb via @statnews “ … leaders will need to think about how to strategically deploy memory-enabled, emotionally intelligent super nudges in a structured yet organic-feeling cadence that
-
-
Mashup Score: 0What David Baker's AI biotech unicorn Xaira has been up to - 4 day(s) ago
This is the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to AI in health care and medicine.
Source: www.statnews.comCategories: General Medicine NewsTweet-
What David Baker’s AI biotech unicorn Xaira has been up to https://t.co/cycSYlOKoK via @statnews " ... protein structure prediction and design has 'come of age' already, but the next frontier is building #AI that can predict biological functions." @Xaira_Thera
-
-
Mashup Score: 0
The development of analgesic drugs targeting sodium channels NaV1.7 and NaV1.8 is described. FDA approval of the NaV1.8 antagonist suzetrigine presages an
Source: rupress.orgCategories: General Medicine NewsTweet-
REVIEW: Sensory neuron sodium channels as #pain targets; from cocaine to #Journavx (VX-548, #suzetrigine) https://t.co/60U759dPjp "There are certainly a range of mechanisms involved in different pain states associated with sensory neurons that reinforce the case for combinatorial https://t.co/lOEs6Of1sW
-
-
Mashup Score: 1
Pain and Therapy – There is a high unmet need for safe and effective non-opioid medicines to treat moderate to severe pain without risk of addiction. Voltage-gated sodium channel 1.8 (NaV1.8) is a…
Source: link.springer.comCategories: General Medicine NewsTweet-
Pharmacology and Mechanism of Action of #Suzetrigine, a Potent and Selective NaV1.8 Pain Signal Inhibitor for the Treatment of Moderate to Severe Pain https://t.co/SRD2KTtpZW #arachnoiditis #acutepain #chronicpain #SCN10A #channels #JOURNAVX "By binding to the VSD2 site located https://t.co/ATssfu105K
-
-
Mashup Score: 1
The fine comes as the DNA testing firm, which filed for bankruptcy in March, is set to be sold to a new owner.
Source: www.bbc.comCategories: General Medicine NewsTweet-
UK watchdog fines 23andMe for 'profoundly damaging' data breach https://t.co/3SGlDTBT9I "According to the ICO, this included access to personal data belonging to 155,592 UK residents, such as names, year of birth, geographical information, profile images, race, ethnicity,
-
-
Mashup Score: 0
This is the same person that 23andMe customers originally trusted with their personal data, albeit under a much more opaque governance structure.
Source: www.axios.comCategories: General Medicine NewsTweet-
23andMe's former CEO agrees to buy the company for $305 million https://t.co/11cY9g52QM $300M Question: Where does 23/TTAM go from here!? Customers who remained loyal are now looking for a clear and reliable plan—particularly in light of two separate Boards of Directors having
-
-
Mashup Score: 1
Technology could be a boon for science, but raises ethical concerns
Source: www.science.orgCategories: General Medicine NewsTweet-
HOW COOL IS THIS?: DNA captured from the air could track wildlife, invasive species—and humans | Science | AAAS https://t.co/0L1cghZQS4
-
-
Mashup Score: 0
The future of the genetic data owned by 23andMe is uncertain as the company undergoes a court-supervised sale.
Source: www.statnews.comCategories: General Medicine NewsTweet-
23andMe leaders grilled on genetic data risks by federal lawmakers 1/2 https://t.co/yYXIqLOXCW via @statnews
-
-
Mashup Score: 0Is Nucleus Genomic rigging the genetic lottery? - 14 day(s) ago
Kian Sadeghi was 25 years old when he decided to monetise human evolution. His company, Nucleus Genomics, charges parents $5,999 to rank their IVF embryos across 900 different traits: everything from projected IQ and height to cancer risk and probable lifespan. The Wall Street Journal reported on it this week and the company has been […]Read More…
Source: unherd.comCategories: General Medicine NewsTweet-
Is Nucleus Genomics rigging the genetic lottery? @UnHerd https://t.co/nXD2EZ8fij $6,000 for an invasive procedure, garnering a certificate that, with certain exceptions, can’t guarantee your #IVF embryos' future traits... And we still don’t know who owns your 23andMe DNA data.
-
RT @Nature: Nature research paper: Single-cell transcriptomic and chromatin dynamics of the human brain in PTSD https://t.co/WwrAU8fdVt